Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Microbiol ; 69(4): 605-616, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32125268

ABSTRACT

Introduction. Against the backdrop of increasing resistance to conventional antibiotics, bacteriocins represent an attractive alternative, given their potent activity, novel modes of action and perceived lack of issues with resistance.Aim. In this study, the nature of the antibacterial activity of a clinical isolate of Streptococcus gallolyticus was investigated.Methods. Optimization of the production of an inhibitor from strain AB39 was performed using different broth media and supplements. Purification was carried out using size exclusion, ion exchange and HPLC. Gel diffusion agar overlay, MS/MS, de novo peptide sequencing and genome mining were used in a proteogenomics approach to facilitate identification of the genetic basis for production of the inhibitor.Results. Strain AB39 was identified as representing Streptococcus gallolyticus subsp. pasteurianus and the successful production and purification of the AB39 peptide, named nisin P, with a mass of 3133.78 Da, was achieved using BHI broth with 10 % serum. Nisin P showed antibacterial activity towards clinical isolates of drug-resistant bacteria, including methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus and penicillin-resistant Streptococcus pneumoniae. In addition, the peptide exhibited significant stability towards high temperature, wide pH and certain proteolytic enzymes and displayed very low toxicity towards sheep red blood cells and Vero cells.Conclusion. To the best of our knowledge, this study represents the first production, purification and characterization of nisin P. Further study of nisin P may reveal its potential for treating or preventing infections caused by antibiotic-resistant Gram-positive bacteria, or those evading vaccination regimens.


Subject(s)
Nisin/isolation & purification , Nisin/pharmacology , Streptococcus gallolyticus/metabolism , Amino Acid Sequence , Animals , Chromatography , Chromatography, High Pressure Liquid , Erythrocytes/cytology , Erythrocytes/drug effects , Gram-Positive Bacteria/drug effects , Hemolysis/drug effects , Molecular Structure , Nisin/chemistry , Nisin/metabolism , Sheep , Streptococcus gallolyticus/chemistry , Streptococcus gallolyticus/classification , Streptococcus gallolyticus/genetics , Tandem Mass Spectrometry
2.
BMC Infect Dis ; 19(1): 791, 2019 Sep 09.
Article in English | MEDLINE | ID: mdl-31500570

ABSTRACT

BACKGROUND: Infections by Streptococcus gallolyticus subsp. pasteurianus (SGSP) is often underestimated. Herein, the epidemiological features and resistant characteristics of SGSP in mainland China are characterized to enable a better understanding of its role in clinical infections. METHODS: In the present work, 45 SGSP isolates were collected from the samples of bloodstream, urine, aseptic body fluid, and fetal membrane/placenta from patients in 8 tertiary general hospitals of 6 cities/provinces in China from 2011 to 2017. The identification of all isolates was performed using traditional biochemical methods, 16S rRNA and gyrB sequencing, followed by the characterization of their antibiotic resistance profiling and involved genes. RESULTS: Among 34 non-pregnancy-related patients, 4 (4/34,11.8%) patients had gastrointestinal cancer, 10 (10/34, 29.4%) patients had diabetes, and one patient had infective endocarditis. Moreover, 11 cases of pregnant women were associated with intrauterine infection (9/11, 81.2%) and urinary tract infection (1/11, 9.1%), respectively. Except one, all other SGSP isolates were correctly identified by the BD Phoenix automated system. We found that all SGSP isolates were phenotypically susceptible to penicillin, ampicillin, cefotaxime, meropenem, and vancomycin. Forty strains (40/45, 88.9%) were both erythromycin and clindamycin-resistant, belonging to the cMLSB phenotype, and the majority of them carried erm(B) gene (39/40, 97.5%). Although the cMLSB/erm(B) constituted the most frequently identified phenotype/genotype combination (25/40, 62.5%) among all erythromycin-resistant cMLSB isolates, erm(B)/erm(A), erm(B)/mef(A/E), and erm(B)/erm(T) was detected in 7, 4, and 3 isolates, respectively. Furthermore, 43 strains (43/45, 95.6%) were tetracycline-resistant, and out of these, 39 strains (39/45, 86.7%) carried tet(L), 27(27/45, 60.0%) strains carried tet(O), and 7 (7/45, 15.6%) strains carried tet(M), alone or combined, respectively. All erythromycin-resistant isolates were also resistant to tetracycline. CONCLUSIONS: It is important to study and draw attention on SGSP, an underreported opportunistic pathogen targeting immunodeficient populations, notably elderly subjects, pregnant women and neonates.


Subject(s)
Bacteremia/pathology , Streptococcal Infections/pathology , Streptococcus gallolyticus/genetics , Uterine Diseases/pathology , Adult , Anti-Bacterial Agents/pharmacology , Bacteremia/microbiology , Bacterial Proteins/genetics , China , Drug Resistance, Bacterial/genetics , Female , Humans , Infant, Newborn , Male , Microbial Sensitivity Tests , Middle Aged , Phenotype , Phylogeny , Pregnancy , RNA, Ribosomal, 16S/chemistry , RNA, Ribosomal, 16S/isolation & purification , RNA, Ribosomal, 16S/metabolism , Streptococcal Infections/microbiology , Streptococcus gallolyticus/classification , Streptococcus gallolyticus/drug effects , Streptococcus gallolyticus/isolation & purification , Uterine Diseases/microbiology , Young Adult
4.
Diagn Microbiol Infect Dis ; 86(4): 329-335, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27720207

ABSTRACT

This study aimed to retrospectively identify 22Streptococcus bovis clinical strains based on the new taxonomy, as well as to investigate their antibiotic-resistance and clonality. Strains were identified by Phoenix100 system, 16S rRNA sequencing, and two MALDI-TOF MS platforms (Bruker Biotyper, Vitek MS). Antibiotic resistance was determined both phenotypically and genotypically, and clonality was assessed by PFGE. Most of strains (63.6%) were isolated from urine, and diabetes was the most common underlying disease (31.8%). Phoenix100 system revealed all strains belonged to biotype II, and 16S rRNA sequencing identified all strains as S. gallolyticus subsp pasteurianus (SGSP). Although both MALDI-TOF MS systems correctly identified isolates to the species level, only Bruker Biotyper accurately identified to the subspecies level. Erythromycin-resistant strains (31.8%) were also clindamycin-resistant and positive for erm(B). Strains resistant to tetracycline (68.2%) were also resistant to erythromycin. PFGE showed high genetic variability identifying 17 different pulsotypes, most of which single.


Subject(s)
Streptococcal Infections/diagnosis , Streptococcal Infections/microbiology , Streptococcus gallolyticus/classification , Streptococcus gallolyticus/isolation & purification , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Bacterial Typing Techniques , DNA, Ribosomal/chemistry , DNA, Ribosomal/genetics , Drug Resistance, Bacterial , Female , Humans , Male , Middle Aged , RNA, Ribosomal, 16S/genetics , Retrospective Studies , Sequence Analysis, DNA , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Streptococcus gallolyticus/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...